NetworkNewsBreaks – Second Sight Medical Products, Inc. (NASDAQ: EYES) Sees Mounting Potential for Argus® II “Bionic Eye” Implants
Second Sight Medical Products (NASDAQ: EYES) develops, manufactures and markets implantable prosthetic devices to restore functional vision to blind patients. The company’s Argus II System is an implantable neurostimulation device that uses electrical stimulation of the retina to replace the function of the defunct photo-receptors in retinitis pigmentosa patients. Second Sight wrapped up 2016 with an announcement that for the first time in the UK, the publicly-funded NHS system would fund blind patients with retinitis pigmentosa (RP) to receive treatment with Second Sight’s innovative Argus® II Retinal Prosthesis System (Argus II) “bionic eye.” The company most recently announced a rights…







